Peptides that selectively home to heart vasculature and related conjugates and methods
The present invention provides a variety of isolated peptides and peptidomimetics, which can be useful, for example, in constructing the conjugates of the invention or, where the peptide itself has biological activity, in unconjugated form as a therapeutic for treating any of a variety of cardiovascular diseases as described below. Thus, the present invention provides an isolated peptide or peptidomimetic which has a length of less than 60 residues and includes the amino acid sequence CRPPR (SEQ ID NO: 1) or a peptidomimetic thereof. The invention further provides an isolated peptide or peptidomimetic which has a length of less than 60 residues and includes the amino acid sequence CARPAR (SEQ ID NO: 5) or a peptidomimetic thereof, or amino acid sequence CPKRPR (SEQ ID NO: 6) or a peptidomimetic thereof.
1. An isolated peptide which selectively homes to heart vasculature, said isolated peptide having a length of less than 40 residues and comprising the amino acid sequence CRPPR (SEQ ID NO:1).
2. The isolated peptide of claim 1 , having a length of less than 35 residues.
3. The isolated peptide of claim 1 , having a length of less than 30 residues.
4. The isolated peptide of claim 1 , having a length of less than 25 residues.
5. The isolated peptide of claim 1 , having a length of less than 20 residues.
6. The isolated peptide of claim 1 , having a length of less than 15 residues.
7. The isolated peptide of claim 1 , having a length of less than 12 residues.
8. The isolated peptide of claim 1 , having a length of less than 10 residues.
9. The isolated peptide of claim 1 , having a length of less than 9 residues.
10. The isolated peptide of claim 1 , having a length of less than 8 residues.
11. The isolated peptide of claim 1 , having a length of less than 7 residues.
12. The isolated peptide of claim 1 , having a length of less than 6 residues.